Skip to main content

Table 4 The effect of HIV infection and different types of antiretroviral therapy, on markers of oxidative stress (carbonyls and TBARs).

From: The effect of different combination therapies on oxidative stress markers in HIV infected patients in cameroon

 

HIV-

HIV+

Groups

Control (n = 90)

pre-HAART (n = 65)

Therapy I (n = 40)

Therapy II (n = 20)

Therapy III (n = 25)

Carbonyls (nmol/mg)

1.07 ± 0.27

1.34 ± 0.98a

0.79 ± 0.10ab

0.93 ± 0.16b

0.81 ± 0.09ab

TBARS (μmol/l)

1.30 ± 0.12

4.20 ± 0.70a

7.02 ± 2.58ab

5.92 ± 1.46ab

5.84 ± 0.89ab

  1. Significant differences (a P < 0.01) are by comparison with the control group (HIV Negative), (b P < 0.001) are by comparison with the HIV positive patients without therapy (pre-HAART)